1. Home
  2. DELL vs AZN Comparison

DELL vs AZN Comparison

Compare DELL & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DELL

Dell Technologies Inc.

HOLD

Current Price

$433.82

Market Cap

191.7B

Sector

Technology

ML Signal

HOLD

Logo AstraZeneca PLC

AZN

AstraZeneca PLC

HOLD

Current Price

$183.09

Market Cap

316.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DELL
AZN
Founded
1984
1992
Country
United States
United Kingdom
Employees
N/A
96100
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.7B
316.4B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
DELL
AZN
Price
$433.82
$183.09
Analyst Decision
Buy
Strong Buy
Analyst Count
17
1
Target Price
$181.63
N/A
AVG Volume (30 Days)
10.0M
1.9M
Earning Date
05-28-2026
04-29-2026
Dividend Yield
1.23%
1.73%
EPS Growth
36.05
N/A
EPS
5.24
N/A
Revenue
$113,538,000,000.00
N/A
Revenue This Year
$26.19
$10.34
Revenue Next Year
$8.60
$6.43
P/E Ratio
$81.66
$31.91
Revenue Growth
18.80
N/A
52 Week Low
$110.22
$68.62
52 Week High
$469.47
$212.71

Technical Indicators

Market Signals
Indicator
DELL
AZN
Relative Strength Index (RSI) 66.98 52.86
Support Level $122.88 $180.98
Resistance Level $469.47 $191.50
Average True Range (ATR) 29.70 2.98
MACD -3.05 0.42
Stochastic Oscillator 81.70 80.83

Price Performance

Historical Comparison
DELL
AZN

About DELL Dell Technologies Inc.

Dell Technologies is a broad information technology vendor, primarily supplying hardware to enterprises. It focuses on premium and commercial personal computers, as well as enterprise on-premises data center hardware. It holds top-three shares in its core markets of personal computers, peripheral displays, mainstream servers, and external storage. Dell has a robust ecosystem of component and assembly partners and also relies heavily on channel partners to fulfill its sales.

About AZN AstraZeneca PLC

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Share on Social Networks: